nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
|
Pollock, Carol |
|
2019 |
7 |
6 |
p. 429-441 |
artikel |
2 |
Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome
|
Perdigoto, Ana Luisa |
|
2019 |
7 |
6 |
p. 421-423 |
artikel |
3 |
Continuous glucose monitoring-based technologies in hypoglycaemia-prone patients with type 1 diabetes
|
Hermanns, Norbert |
|
2019 |
7 |
6 |
p. 419-421 |
artikel |
4 |
Correction to Lancet Diabetes Endocrinol 2019; 7: 34–43
|
|
|
2019 |
7 |
6 |
p. e18 |
artikel |
5 |
Correction to Lancet Diabetes Endocrinol 2019; 7: 339–41
|
|
|
2019 |
7 |
6 |
p. e18 |
artikel |
6 |
Correction to Lancet Diabetes Endocrinol 2019; 7: 385–96
|
|
|
2019 |
7 |
6 |
p. e18 |
artikel |
7 |
Da Qing 30 years on: more reasons to extend diabetes prevention
|
Lean, Michael E J |
|
2019 |
7 |
6 |
p. 417-419 |
artikel |
8 |
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data
|
Dennis, John M |
|
2019 |
7 |
6 |
p. 442-451 |
artikel |
9 |
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial
|
Bosi, Emanuele |
|
2019 |
7 |
6 |
p. 462-472 |
artikel |
10 |
Gender-affirming hormones and surgery in transgender children and adolescents
|
Mahfouda, Simone |
|
2019 |
7 |
6 |
p. 484-498 |
artikel |
11 |
Insulin resistance underlying type 2 diabetes
|
Lima, Luís Maurício T R |
|
2019 |
7 |
6 |
p. 424 |
artikel |
12 |
Insulin resistance underlying type 2 diabetes – Authors' reply
|
Schmidt, Maria I |
|
2019 |
7 |
6 |
p. 424-425 |
artikel |
13 |
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study
|
Gong, Qiuhong |
|
2019 |
7 |
6 |
p. 452-461 |
artikel |
14 |
Nutrition, weight loss, and type 2 diabetes
|
The Lancet Diabetes & Endocrinology, |
|
2019 |
7 |
6 |
p. 413 |
artikel |
15 |
Potential antitumour activity of pasireotide on pituitary tumours in acromegaly
|
Coopmans, Eva C |
|
2019 |
7 |
6 |
p. 425-426 |
artikel |
16 |
Predicting individual treatment response in diabetes
|
Heerspink, Hiddo J L |
|
2019 |
7 |
6 |
p. 415-417 |
artikel |
17 |
Psychological support for bariatric surgery
|
Scholtz, Samantha |
|
2019 |
7 |
6 |
p. 428 |
artikel |
18 |
Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers
|
Jonklaas, Jacqueline |
|
2019 |
7 |
6 |
p. 473-483 |
artikel |
19 |
Research digest: SGLT2 inhibition in kidney and liver disease
|
Preiss, David |
|
2019 |
7 |
6 |
p. 427 |
artikel |
20 |
SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease
|
Tuttle, Katherine R |
|
2019 |
7 |
6 |
p. 414-415 |
artikel |